中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01763 中国同辐

休市中 12-19 16:08:04

21.020

+0.320

+1.55%

最高21.480	最低21.020	成交量8.16万
今开21.040	昨收20.700	日振幅2.22%
总市值67.26亿	流通市值16.81亿	总股本3.20亿
成交额173.37万	换手率0.10%	流通股本7,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":21.02,"timestamp":1766131684511,"preClose":20.7,"halted":0,"volume":81600,"delay":0,"floatShares":79968800,"shares":320000000,"eps":1.4076484724960896,"marketStatus":"休市中","change":0.32,"latestTime":"12-19 16:08:04","open":21.04,"high":21.48,"low":21.02,"amount":1733728,"amplitude":0.022222,"askPrice":21.06,"askSize":3600,"bidPrice":21.02,"bidSize":2400,"shortable":0,"etf":0,"ttmEps":1.468220246364068,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":7,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":20.7,"dividendRate":0.020273,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":0.5676126873392214,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2592741169","title":"中国同辐(01763)附属公司中核海得威BNCT硼药获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2592741169","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592741169?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:03","pubTimestamp":1766145788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，国家药品监督管理局药品审评中心官网信息显示公司附属公司深圳市中核海得威生物科技有限公司自主研发的2.2类改良新药“注射用硼[10B]法仑”临床试验申请获批。此外，中核海得威“注射用硼[10B]法仑”临床试验申请获批标志着中核海得威BNCT药械协同研发领域取得突破性成果，正式迈入临床转化新阶段，为“健康中国”战略下的精准肿瘤治疗注入核科技新动能，为全球肿瘤治疗贡献“中国方案”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2591835579","title":"中国同辐12月16日遭主力抛售39.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591835579","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591835579?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872959,"startTime":"0","endTime":"0","summary":"12月16日, 中国同辐股价跌1.66%，报收20.20元，成交金额523.7万元，换手率0.32%，振幅4.48%，量比1.14。中国同辐今日主力资金净流出39.2万元，上一交易日主力净流出41.8万元。该股近5个交易日上涨1.61%，主力资金累计净流出131.1万元；近20日主力资金累计净流出981.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162238a4519130&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162238a4519130&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2591983377","title":"中核集团攻克富集靶材辐照制备碘-131全链条技术 核药市场呈现高速增长（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983377?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:41","pubTimestamp":1765845673,"startTime":"0","endTime":"0","summary":"平台充分发挥集团内部协同创新优势，整合中国原子能所属核理化院、核动力院、中核高通、中核二七二铀业，攻克富集 TeO 靶材辐照制备碘-131全产业链技术，形成了从碘-131前置核素制备、反应堆辐照到核药研发的完整环境友好型自主产业链。中国同位素与辐射行业协会秘书长郭丽莉介绍，截至2024年，国家药监局批准上市的放射治疗设备超90款，其中国产品牌占比超七成，彻底改变了此前依赖进口设备的局面。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191","01763","BK1161","01244","BK1222"],"gpt_icon":0},{"id":"2591867868","title":"智通港股早知道 | 磷酸铁锂迎来涨价潮 特斯拉(TSLA.US)创近一年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2591867868","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591867868?lang=zh_cn&edition=full","pubTime":"2025-12-16 07:43","pubTimestamp":1765842190,"startTime":"0","endTime":"0","summary":"大型科技股多数下跌，博通跌超5%，苹果、亚马逊、美光科技跌超1%，特斯拉涨超3%创近一年新高，英伟达涨0.73%。部分企业甚至表示，涨价趋势预计将持续至明年第四季度。12月15日，国联通智基金召开合伙人会议，决定解散该基金并办理工商注销手续，由国联通宝牵头负责清算及注销登记等事宜。本次担保发生后，公司及控股子公司对外担保总额将为844.93亿元，占公司2024年末经审计归属于上市公司股东净资产的比重将为41.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1778281490.HKD","LU2750360997.AUD","LU0820562030.AUD","BK4581","LU0708995401.HKD","LU1839511570.USD","BK4533","LU0672654240.SGD","TSLA","LU2236285917.USD","LU2403377893.USD","TSLL","LU2896262040.SGD","LU1914381329.SGD","BK4555","LU1066051225.USD","LU2756315664.SGD","BK4527","LU1861558580.USD","BK4550","LU2602419157.SGD","BK4551","SG9999015986.USD","IE00B19Z9505.USD","TSYW.SI","LU1232071149.USD","LU1861220033.SGD","LU0823414478.USD","IE00BSNM7G36.USD","LU2250418816.HKD","LU0198837287.USD","LU1551013342.USD","LU2750360641.GBP","LU1366192091.USD","LU0097036916.USD","LU2360106780.USD","LU2108987350.USD","LU2249611893.SGD","BK4534","IE00B19Z8W00.USD","LU0348723411.USD","SG9999015945.SGD","LU0345769631.USD","LU0345770308.USD","LU2420271590.USD","LU2213496289.HKD","BK4099","IE00B1BXHZ80.USD","01763","BK4612"],"gpt_icon":1},{"id":"2591644130","title":"中国同辐(01763)附属原子高科参与“儿童神经母细胞瘤多模态核医学分子影像体系的建立”项目荣获北京医学科技奖一等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2591644130","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591644130?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:58","pubTimestamp":1765807117,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，由原子高科股份有限公司参与完成的“儿童神经母细胞瘤多模态核医学分子影像体系的建立”项目，荣获本年度北京医学科技奖一等奖。本项目由友谊医院牵头完成，原子高科作为本项目创新内容二“核素药物的研发”的核心牵头单位，在神经母细胞核素药物研发方面做了长期、大量的工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2591649704","title":"中国同辐(01763)附属原子高科与诺华公司签署商业合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649704","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649704?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:15","pubTimestamp":1765804518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司附属公司原子高科股份有限公司(原子高科)与诺华医药科技(浙江)有限公司(诺华公司)正式签署派威妥®(镥[177Lu]特昔维匹肽注射液)商业合作协议(商业合作协议)。派威妥® 是国内首个且目前唯一获批的靶向PSMA的放射配体疗法药物，主要用于治疗晚期前列腺癌，未来将为患者提供延长生命并改善生活质量的全新核药治疗方案。此次签约开启了双方在创新核药产品派威妥®方面的战略合作，原子高科将凭藉在放射性药物领域的多年合规运营经验，与诺华公司强强联合，为医疗机构和患者提供定制化的派威妥®产品供应与解决方案，以惠及更多的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK1222","BK4585","LU0208291251.USD","BK4578","BK4532","LU0211331839.USD","01763","LU0070302665.USD","NVS","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","BK4588","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765489.SGD"],"gpt_icon":0},{"id":"1160407632","title":"中国同辐子公司与诺华制药技术（浙江）签署商业合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1160407632","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160407632?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:13","pubTimestamp":1765804398,"startTime":"0","endTime":"0","summary":"中国同辐子公司与诺华制药技术（浙江）签署了商业合作协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2590519118","title":"中国同辐(01763)：附属与北师大签署氟[18F]贝他嗪一类创新核药专利转让协议及产学研项目合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2590519118","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590519118?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:36","pubTimestamp":1765460170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，2025年12月10日，原子高科股份有限公司与北京师范大学在北京举办科技成果转化签约暨产学研合作交流会，共同签署了氟[18F]贝他嗪项目《专利转让协议》与《产学研合作协议》。氟[18F]贝他嗪是北京师范大学崔孟超教授团队与原子高科合作研发的成果，为具有完全自主知识产权的一类新药，主要用于阿尔茨海默病的早期诊断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国同辐(01763)：附属与北师大签署氟[18F]贝他嗪一类创新核药专利转让协议及产学研项目合作协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2590362181","title":"中国同辐12月08日主力净流出11.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590362181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590362181?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:16","pubTimestamp":1765181762,"startTime":"0","endTime":"0","summary":"12月08日, 中国同辐股价跌3.30%，报收20.50元，成交金额528.4万元，换手率0.32%，振幅2.08%，量比1.07。中国同辐今日主力资金净流出11.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.73%，主力资金累计净流出113.6万元；近20日主力资金累计净流出1252.4万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816225797960dc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816225797960dc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"1154121261","title":"中國同辐（01763）2025年11月无新增发行，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1154121261","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154121261?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:50","pubTimestamp":1764579059,"startTime":"0","endTime":"0","summary":"中國同辐股份有限公司（01763）于2025年12月1日发布2025年11月股份变动月报表，报告期截至2025年11月30日。根据公告，公司本月未有任何新增发行、购回或注销股份活动，整体股本保持稳定。\n截至月末，公司注册股本总额约为人民币319,874,900元，其中包括79,968,800股H股及239,906,100股内资股，与上月底持平。据公告披露，当月并无涉及股份期权规划、购回股份或发行任何新权益性工具。\n公司同时确认，相关变动已遵守香港联交所《上市规则》及适用法律法规规定。公告由联席公司秘书王仓忍于2025年12月1日签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"gpt_icon":0},{"id":"2586213012","title":"中国同辐(01763)与中核资本签署《战略合作协议》 以金融资本赋能高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213012","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213012?lang=zh_cn&edition=full","pubTime":"2025-11-27 12:05","pubTimestamp":1764216300,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)公布，11月27日，在中国核工业集团有限公司、中国同位素与辐射行业协会主办的第二届核技术应用产业链共链行动大会上，中国同辐与中国核工业集团资本控股有限公司(中核资本)签署《战略合作协议》。根据《战略合作协议》，双方将聚焦推动核技术应用产业链整合、突破关键技术“卡脖子”瓶颈、培育新质生产力的核心目标，通过资源共享、优势互补，在并购扩张、新设公司、股权投资、证券业务等方面开展深度协作，构建科技与金融、产业与金融协同发展新格局，以金融资本赋能中国同辐实现高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国同辐(01763)与中核资本签署《战略合作协议》 以金融资本赋能高质量发展","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2586591422","title":"中国同辐11月25日主力净流出541.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586591422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586591422?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:15","pubTimestamp":1764058527,"startTime":"0","endTime":"0","summary":"11月25日, 中国同辐股价跌1.31%，报收21.04元，成交金额1281.9万元，换手率0.74%，振幅5.07%，量比1.68。中国同辐今日主力资金净流出541.8万元，上一交易日主力净流出0万元。该股近5个交易日下跌5.36%，主力资金累计净流出694.7万元；近20日主力资金累计净流出351.7万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516171795192384&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516171795192384&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2584595848","title":"中国同辐(01763)自产辐照设备首次出口拉美市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2584595848","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584595848?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:49","pubTimestamp":1763473747,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，当地时间2025年11月17日，中国同辐与秘鲁业主在利马正式签署农业用伽马辐照站项目合同。根据协议，中国同辐将提供专业伽马辐照装置，并供应配套辐照钴源的整体方案。项目建成后，将主要应用于农产品的辐照处理，旨在提高灭菌水平、延长产品上架期，进一步提升秘鲁特色农产品的出口质量和市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2584957321","title":"中国同辐11月18日遭主力抛售159.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584957321?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453734,"startTime":"0","endTime":"0","summary":"11月18日, 中国同辐股价跌3.12%，报收22.38元，成交金额1249.2万元，换手率0.68%，振幅8.57%，量比0.69。中国同辐今日主力资金净流出159.3万元，上一交易日主力净流出171.4万元。该股近5个交易日下跌1.32%，主力资金累计净流出627.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入445.6万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181618089770b34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181618089770b34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2584694640","title":"中国同辐(01763)与巴西国家核能委员会签署辐照钴-60放射源意向采购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2584694640","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584694640?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:52","pubTimestamp":1763380379,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，近日，中国同辐与巴西国家核能委员会(CNEN)签署《辐照钴-60放射源意向采购协议》，标志着中国同辐自产辐照钴-60放射源将首次出口拉美市场，同时也是双方践行2025年10月签署的《同位素采购领域合作谅解备忘录》框架下首个实质性合作成果。根据《辐照钴-60放射源意向采购协议》，CNEN将从中国同辐采购辐照钴-60放射源，用于提升其下属巴西核与能源研究院(IPEN)多功能辐照设施辐照能力，更好地应用于技术研发、材料研究、辐照加工等多领域，持续推动辐照技术惠及巴西社会民生。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["URA","01763","BK4588","159100","BK4585","BK4606","BK1222"],"gpt_icon":0},{"id":"1116823917","title":"中国同辐 - Cnen 将从 CIRC 采购用于照射的钴-60 放射源","url":"https://stock-news.laohu8.com/highlight/detail?id=1116823917","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116823917?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:51","pubTimestamp":1763380270,"startTime":"0","endTime":"0","summary":"中国同辐 - Cnen 将从 CIRC 采购用于照射的钴-60 放射源","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2583512890","title":"中国同辐11月13日遭主力抛售42.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583512890?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:15","pubTimestamp":1763021747,"startTime":"0","endTime":"0","summary":"11月13日, 中国同辐股价跌1.23%，报收24.10元，成交金额1178.2万元，换手率0.61%，振幅3.61%，量比0.35。中国同辐今日主力资金净流出42.1万元，上一交易日主力净流出254.9万元。该股近5个交易日上涨15.31%，主力资金累计净流出223.3万元；近20日主力资金累计净流入885.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131620549766ab79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131620549766ab79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2582320235","title":"瑞银增持中国同辐(01763)8.84万股 每股作价约20.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582320235","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582320235?lang=zh_cn&edition=full","pubTime":"2025-11-12 19:06","pubTimestamp":1762945589,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月6日，瑞银增持中国同辐(01763)8.84万股，每股作价20.8565港元，总金额约为184.37万港元。增持后最新持股数目约为400.49万股，最新持股比例为5.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2582100053","title":"中国同辐(01763.HK)再涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582100053","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582100053?lang=zh_cn&edition=full","pubTime":"2025-11-12 11:00","pubTimestamp":1762916450,"startTime":"0","endTime":"0","summary":"每经AI快讯，中国同辐(01763.HK)再涨超8%，年内股价累涨逾130%。截至发稿，涨7.94%，报24.48港元，成交额1302.97万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511123562038477.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511123562038477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2582310965","title":"港股异动 | 中国同辐(01763)再涨超8% 诺华核药在华获批上市 有望点燃国内核医学行业热度","url":"https://stock-news.laohu8.com/highlight/detail?id=2582310965","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582310965?lang=zh_cn&edition=full","pubTime":"2025-11-12 10:55","pubTimestamp":1762916116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国同辐再涨超8%，年内股价累涨逾130%。截至发稿，涨7.94%，报24.48港元，成交额1302.97万港元。消息面上，11月5日，诺华宣布其放射配体疗法药物Pluvicto的两个适应症同时获得国家药监局批准。据悉，Pluvicto为诺华旗下的一款核药爆品。平安证券指出，Pluvicto的获批有望进一步点燃国内核医学行业热度，AD诊断核药有望随着治疗药物一同放量，建议关注国内在新核素和新靶点方面布局领先的企业，比如中国同辐等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","BK4585","NVS","BK1222","IE00BFTCPJ56.SGD","BK4007","IE00B2B36J28.USD","BK4532","LU0070302665.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","IE0002141913.USD","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","01763"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":-0.0574},{"period":"3month","weight":0.3389},{"period":"6month","weight":0.4296},{"period":"1year","weight":1.0481},{"period":"ytd","weight":1.0065}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0054},{"period":"3month","weight":-0.0322},{"period":"6month","weight":0.0918},{"period":"1year","weight":0.3006},{"period":"ytd","weight":0.2807}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.02846},{"month":2,"riseRate":0.571429,"avgChangeRate":0.052162},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.034143},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.013249},{"month":5,"riseRate":0.571429,"avgChangeRate":0.015374},{"month":6,"riseRate":0.571429,"avgChangeRate":0.05564},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.022851},{"month":8,"riseRate":0.5,"avgChangeRate":0.038573},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029064},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037438},{"month":11,"riseRate":0.75,"avgChangeRate":0.064344},{"month":12,"riseRate":0.5,"avgChangeRate":0.006317}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}